We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editor's Correspondence |

Breast Cancer Prevention: Time for Randomized Controlled Trials With Statins—Reply

A. Heather Eliassen, ScD; Susan E. Hankinson, ScD
Arch Intern Med. 2006;166(10):1143-1144. doi:10.1001/archinte.166.10.1144-a.
Text Size: A A A
Published online


In reply

We appreciate the comments by Sprague and Wood and Kumar et al and the opportunity to reply. While in vitro and animal data suggest that statins may protect against breast cancer, it is important to weigh all available evidence before conducting a randomized controlled trial of statin use in the prevention of breast cancer. Thus far the cumulative evidence is not compelling, with epidemiologic evidence to date leaning toward no association, as noted by Sprague and Wood. As we noted in our article,1 we agree that further study is needed to evaluate this association with longer durations of use and by estrogen receptor status of the tumor. Given the relatively recent widespread use of statins, even in a large observational study such as ours, the number of long-term users is still small, such that there are relatively few breast cancer cases among users. Also as we noted, we were unable to address the importance of hydrophilic vs lipophilic statins, or specific statin drugs, within the Nurses' Health Study. However, in a recent large meta-analysis, Dale et al2 found no association between statin use and overall cancer incidence (odds ratio [OR], 1.02) or mortality (OR, 1.01), and the null association was evident for both hydrophilic and lipophilic statins. In addition, no significant association was observed with breast cancer incidence, and the OR was not suggestive of a protective effect (OR, 1.33; 95% confidence interval, 0.79-2.26).

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
The Biological Agent

Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice, 3rd ed
Is There Potentially Compelling Evidence for a Class Effect?